Avidity Partners Management LP Madrigal Pharmaceuticals, Inc. Transaction History

Avidity Partners Management LP

  • $885 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $25.1 Million - $128 Million
430,000 New
430,000 $125 Million
Q1 2020

May 15, 2020
SELL
$66.76 - $93.49 $1 Million - $1.4 Million
-15,000 Closed
0 $0
Q4 2019

Jun 17, 2020
BUY
$84.28 - $118.5 $1.26 Million - $1.78 Million
15,000 New
15,000 $1.37 Million

Others Institutions Holding MDGL

# of Institutions
335
Shares Held
22.3M
Call Options Held
960K
Put Options Held
940K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $6B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email